Evidence map›Paper›PMID 40637061›Full record

ArticleJournal of cachexia, sarcopenia and muscle2025

Global Burden of Musculoskeletal Disorders in Adults Aged 50 and Over, 1990-2021: Risk Factors and Sociodemographic Inequalities.

Shi-Yang Guan, Jin-Xin Zheng, Shun-Xian Zhang, Shengqian Xu, Zongwen Shuai, Hong-Yan Cai, Faming Pan

Abstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shi-Yang GuanDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Jin-Xin ZhengSchool of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shun-Xian ZhangClinical Research Center, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Shengqian XuDepartment of Rheumatism and Immunity, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Zongwen ShuaiDepartment of Rheumatism and Immunity, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Hong-Yan CaiDepartment of Nephrology, Anhui No. 2 Provincial People's Hospital, Hefei, Anhui, China.
Faming PanDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.

Funding

Academic and Technical Leaders Foundation of Anhui Province 2017D140National Natural Science Foundation of China 82073655National Natural Science Foundation of China 82373672Research Innovation Team Project of School of Public Health, Anhui Medical University kctd200403Scientific Research Level Upgrading Project of Anhui Medical University 2020xkjT006
6 · The paper itself

Abstract

backgroundAdults aged 50 and over are particularly vulnerable to musculoskeletal (MSK) disorders, with their impact expected to intensify as the global population ages. This study aims to comprehensively assess the global burden of MSK disorders among adults aged 50 and over from 1990 to 2021, as well as temporal trends, risk factors and sociodemographic inequalities.

methodsData were sourced from the Global Burden of Disease 2021 study. Temporal trends in age-standardized rates were evaluated by calculating average annual percent changes (AAPC). Absolute and relative inequalities were assessed using the slope index of inequality and concentration index, respectively.

resultsFrom 1990 to 2021, MSK disorders remained the largest contributor to total years lived with disability (YLDs) among adults aged 50 and over globally. The global age-standardized incidence rate significantly decreased (AAPC = -0.181, 95% CI: -0.190 to -0.172), whereas the global prevalence and disability-adjusted life-year (DALY) rates significantly increased (AAPC = 0.126, 95% CI: 0.118-0.134, and AAPC = 0.057, 95% CI: 0.042-0.072, respectively). High sociodemographic index (SDI) countries exhibited the highest age-standardized incidence, prevalence and DALY rates (11 236.6, 56 308.1 and 5277.1 per 100 000 population, respectively), whereas low-middle SDI countries showed the most rapid increases in prevalence and DALY rates (AAPC = 0.229, 95% CI: 0.218-0.240, and AAPC = 0.230, 95% CI: 0.204-0.256, respectively). Significantly positive associations were identified between SDI and age-standardized incidence, prevalence and DALY rates (all p < 0.001). High body mass index (BMI) was the largest contributor to global DALYs of MSK disorders, accounting for 10.3% of the total in this population, whereas occupational ergonomic factors, smoking and kidney dysfunction contributed 7.3%, 6.0% and 0.2%, respectively. Although the proportions of DALYs due to occupational ergonomic factors and smoking declined globally (from 9.2% to 7.3% and from 8.9% to 6.0%, respectively), those due to high BMI and kidney dysfunction increased (from 7.7% to 10.3% and from 0.19% to 0.22%, respectively). Both absolute and relative SDI-related inequalities persisted across 204 countries and territories, with no significant changes observed.

conclusionsMSK disorders have remained the largest contributor to disability among adults aged 50 and over. Despite significant progress in reducing the incidence rate, both the prevalence and DALY rates have significantly increased. With the expanding global ageing population, there is an urgent need for improved prevention strategies to mitigate the long-term impacts of MSK disorders in this vulnerable population.

Indexed as

Musculoskeletal DiseasesAgedAged, 80 and overDisability-Adjusted Life YearsFemaleGlobal Burden of DiseaseGlobal HealthHumansIncidenceMaleMiddle AgedPrevalenceRisk FactorsSociodemographic FactorsSocioeconomic Factorsglobal burdeninequalitiesmusculoskeletal disorderstemporal trends

Identifiers

PMID40637061
PMCPMC12242706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.